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Fine-tuning p53 activity through
C-terminal modification significantly
contributes to HSC homeostasis
and mouse radiosensitivity
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Missouri 63110, USA; 9Department of Medicine, Washington University Medical School, St. Louis, Missouri 63110, USA; 10the
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Cell cycle regulation in hematopoietic stem cells (HSCs) is tightly controlled during homeostasis and in response
to extrinsic stress. p53, a well-known tumor suppressor and transducer of diverse stress signals, has been
implicated in maintaining HSC quiescence and self-renewal. However, the mechanisms that control its activity in
HSCs, and how p53 activity contributes to HSC cell cycle control, are poorly understood. Here, we use
a genetically engineered mouse to show that p53 C-terminal modification is critical for controlling HSC
abundance during homeostasis and HSC and progenitor proliferation after irradiation. Preventing p53 C-terminal
modification renders mice exquisitely radiosensitive due to defects in HSC/progenitor proliferation, a critical
determinant for restoring hematopoiesis after irradiation. We show that fine-tuning the expression levels of the
cyclin-dependent kinase inhibitor p21, a p53 target gene, contributes significantly to p53-mediated effects on the
hematopoietic system. These results have implications for understanding cell competition in response to stresses
involved in stem cell transplantation, recovery from adverse hematologic effects of DNA-damaging cancer
therapies, and development of radioprotection strategies.
[Keywords: p53; C-terminal modification; HSC; radiosensitivity; cell cycle; apoptosis]
Supplemental material is available for this article.
Received December 20, 2010; revised version accepted May 26, 2011.

In its most-studied role, p53 acts as a tumor suppressor
that responds to DNA damage, oncogenic, and other
cellular stresses to maintain genomic stability (for review, see Toledo and Wahl 2006). However, accumulating
evidence reveals other functions for p53 in cell metabolism, the inflammatory response, angiogenesis, reproduction, embryogenesis, and stem cell renewal (Vousden and
Prives 2009). These recent observations suggest that p53
may have evolved due to its roles in biological development with tumor suppression being an additional benefit
(Aranda-Anzaldo and Dent 2007).
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p53 is critical for maintaining the balance between cell
survival and apoptosis during development and homeostasis, often in response to stress. The hematopoietic
system is particularly vulnerable to genotoxic stresses such
as radiation, which activates p53 and results in dosedependent acute marrow failure due to apoptosis in highly
proliferative progenitors and mature blood cells (Gudkov
and Komarova 2003). The p53-regulated proapoptotic gene
puma is also recently shown to be critical in modulating
the function of hematopoietic stem and progenitor cells in
response to high-dose irradiation (Shao et al. 2010; Yu et al.
2010). Hematopoietic system restoration relies on the
hematopoietic stem cells (HSCs) that reside in the bone
marrow (BM). HSCs sustain hematopoiesis through selfrenewal, proliferation, and generation of differentiated
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progeny of distinct blood cell lineages. Radiation-induced
damage in the HSC compartment, or forcing HSCs to
undergo rapid proliferation, can lead to HSC exhaustion
and long-term myelosuppression (Cheng et al. 2000; Wang
et al. 2006), which is a common side effect observed in
cancer patients receiving chemotherapy and extensive
radiation therapy.
Several recent studies using mouse models suggest
a critical role for the p53 pathway in HSC self-renewal
and quiescence, as p53-null mice exhibit an increased pool
of HSCs and their HSCs are more resistant to radiationinduced senescence (TeKippe et al. 2003; Meng et al. 2003;
Wang et al. 2006; Chen et al. 2008; Liu et al. 2009).
However, precise regulation of p53 activity is likely to be
important in determining the response of HSCs and proliferative progenitors to irradiation. Thus, insufficient p53
activation should favor cell survival, but put cells at risk
for loss of genomic integrity. In contrast, excessive p53
activation could compromise steady-state hematopoiesis
and its recovery following exogenous marrow insult by
causing too many cells to be eliminated. While insight has
been gained into the impact of p53 itself on radiation
sensitivity in the hematopoietic system, such studies have
commonly used p53-deficient mice, which are of limited
utility as they tend to develop tumors very rapidly (within
3 mo of age) and the heterozygotes quickly succumb to
radiation-induced lymphomas (Kemp et al. 1994). This
precludes evaluating the mechanisms of radioresistance,
which requires dynamic and prolonged observation of
radiation effects on hematopoietic cell kinetics. Moreover,
p53-null models do not enable analyses of the roles of
factors that control p53 level or activity, and these are
likely to be critically important. For example, slight increases in p53 activity caused by reduced expression of p53
inhibitors Mdm2 and Mdmx render mice more radiosensitive (Mendrysa et al. 2003; Terzian et al. 2007). Conversely, mice encoding a stable form of Mdmx are impressively radioresistant despite modest reduction of p53
activity (Wang et al. 2009). However, whether the differences in radiosensitivity associated with altered p53
activity in these models reside in mature blood cells, the
proliferative pool, the HSC compartment, or a combination
of these, and the molecular mechanisms by which p53
activation elicits the observed phenotypes, remain to be
determined.
In vitro and in vivo studies show that p53 activity is
determined to a significant extent by mechanisms that
regulate its abundance and stability. Mdm2 and Mdmx
reduce p53 activity by binding to the N-terminal p53
transactivation domain (TAD) and by promoting ubiquitin-dependent p53 degradation (for review, see Wade et al.
2010). Control of p53 degradation is thought to partially
require ubiquitylation of highly conserved C-terminal
lysine residues (Rodriguez et al. 2000). The same lysines
can also be acetylated by coactivators such as p300 and
CBP to promote transactivation of target genes (for review,
see Kruse and Gu 2009). In vitro studies suggest a model in
which p53 is activated by damage-mediated kinases that
induce phosphorylation in N-terminal serines to produce
a conformational change leading to Mdm2/Mdmx dissoci-

ation and p300/CBP recruitment (Appella and Anderson
2001). These factors then acetylate the C terminus to
stabilize p53 and enhance its transcriptional activity.
However, in vivo, these modifications appear to be dispensable during embryogenesis, and do not significantly
affect p53 activity in mouse embryonic fibroblasts (MEFs)
(Krummel et al. 2005; Feng et al. 2005). This does not
address tissue and condition-specific effects of these residues in vivo, nor whether such effects would be manifested
through regulation of a subset of p53 target genes. Evidence
of the importance of lysine modification for p53 in vivo
functions comes from recent studies showing that mutation of K120 impairs puma activation (Tang et al. 2006),
and that a K120R/K164R double mutant reduces induction
of puma and p21, but not mdm2 (Tang et al. 2008). Thus,
lysine modifications in the DNA-binding region appear to
play a key role in differential gene regulation.
These observations led us to examine more deeply the
impact of modification of the conserved seven C-terminal
lysine residues in a knock-in model in which they were
replaced with arginine (7KR) to prevent ubiquitylation or
acetylation (Krummel et al. 2005). Here, we show that the
p537KR mutation plays a critical role in regulating p53
transcriptional activity on a subset of genes in the hematopoietic system. This, in turn, affects maintenance of
HSCs during unchallenged homeostatic growth, in the
setting of BM transplantation, and after radiation exposure. Notably, the p537KR mutation causes extraordinary
radiosensitivity, which is partially rescued by loss of a
single p21 allele, implicating C-terminal modification in
controlling p21 transcription in the HSC and progenitor
pools that play critical roles in radiation responses.
Results
Wild-type (WT) and p537KR mutant mice have similar
life spans
We first asked whether p537KR elicits a premature aging
phenotype, as reported previously for some mouse mutants with elevated p53 activity (e.g., see Garcı́a-Cao
et al. 2002; Tyner et al. 2002). As such, we followed a
large cohort of p537KR and WT animals to ascertain potential aging phenotypes. The data clearly show that the
life span is similar between mutant mice and their WT
littermates, and that the mutant mice do not display
obvious signs of premature aging (Supplemental Fig. S1).
Preventing p53 C-terminal modification engenders
exquisite radiosensitivity due to multiple
hematopoietic system defects
To determine whether p537KR mice have altered biological responses to DNA damage, mutant and wild-type
(WT) mice were subjected to a range of sublethal doses of
whole-body g-irradiation (4, 5, and 6 Gy). As expected, all
WT mice survived these exposures. In contrast, p537KR
mice in the same genetic background exhibited a striking
dose-dependent response to irradiation: Only ;55% of
p537KR mice were alive at 4 wk after 5 Gy irradiation,
while 100% of p537KR mice died within 4 wk following
6 Gy irradiation (Fig. 1A).
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Figure 1. Preventing C-terminal modification of p53 engenders
exquisite radiosensitivity, particularly in the hematopoietic system. (A) Kaplan-Meier radiation survival curves in WT mice and
p537KR (7KR) mice after 4, 5, and 6 Gy of whole-body irradiation
showing dose-dependent mortality in p537KR mice (4 Gy: n = 58,
P < 0.001; 5 Gy: n = 25, P < 0.001; 6 Gy: n = 10, P < 0.001). (B)
Increased cardiac weights and enlarged hearts in irradiated
p537KR mice 4 wk after 5 Gy of irradiation. Error bars represent
the SEM from four animals. The representative hearts from
nonirradiated and irradiated mice are shown in the picture. (C)
H&E staining of thymus, spleen, and BM from a p537KR mouse
that died after exposure to 5 Gy of whole-body irradiation.

After irradiation, the mutant mice exhibited pallor of
the carcass, low hematocrit, and enlarged hearts (Fig. 1B).
Based on prior studies (Fauci et al. 2008), these observations are consistent with death resulting from heart
failure secondary to severe anemia. Indeed, pathological
evaluation showed that the radiation-induced lesions in
p537KR mice were confined to the hematopoietic organs
(Fig. 1C; Supplemental Fig. S2). Importantly, no significant differences were observed between WT and p537KR
mice in other organs including radiosensitive tissues such
as the gastrointestinal tract (Supplemental Fig. S2; data
not shown).
To expand on these results, we compared complete blood
counts (CBCs) in WT and p537KR mice prior to and 2 wk
following 5 Gy irradiation. This time point was chosen
because myeloablation in mice has been shown to occur
within 2 wk of irradiation followed by recovery by ;4 wk
(Uchida et al. 1994). We found that p537KR mice exhibit
slightly lower blood counts at baseline (mutant = 80%–
90% of WT levels) (Fig. 2A,C). Consistent with previous
studies (Wang et al. 2009), we observed a marked decrease
in white blood cell (WBC) counts and a mild decrease in
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red blood cell (RBC) and platelet counts in WT mice 2 wk
post-irradiation (Fig. 2B). These changes are p53-dependent, as mild-to-no changes in CBCs occurred in p53-null
mice (Fig. 2B). On the other hand, p537KR mice exhibited
more severe decreases in all three blood lineages 2 wk
post-irradiation (mutant ;30%–50% of WT) (Fig. 2B,C).
Histology of the BM and spleen, the major hematopoietic organs in mice, revealed no visible differences between
WT and p537KR mice prior to irradiation (Supplemental Fig.
S2). Two weeks after 5 Gy irradiation, WT BM and spleens
exhibited moderate to robust intra- and extramedullary
hematopoiesis, which gradually abated to near baseline by
4 wk as blood counts returned to normal (Supplemental
Fig. S2). p537KR mice exhibited more dramatic changes in
hematopoietic organs. As such, some mutants showed
robust intra- and extramedullary hematopoiesis in response to the severe radiation-induced pancytopenia,
while others displayed severe atrophy of the hematopoietic BM and splenic red pulp (Supplemental Fig. S2). Both
observations are consistent with increased radiosensitivity
in the hematopoietic system of the p537KR mice. At 4 wk,
mutant mice showed intra- and extramedullary hematopoiesis, indicative of continued stimulation from persistent pancytopenia. Importantly, hematopoiesis was not
sufficient to compensate for the marked pancytopenia in
time to ensure survival of half of the mutant mice.
Consistent with the survival curve (Fig. 1A), 6 Gy irradiation translated histopathologically as a more severe
atrophy in the BM and spleen (Supplemental Fig. S2).
The peripheral pancytopenia observed in irradiated
p537KR mice could reflect impaired hematopoietic stem
and progenitor cell survival, proliferation, or differentiation defects, increased blood cell destruction, or a combination of these. Importantly, responses measured by
peripheral blood cell counts can underestimate a progenitor cell phenotype, as the post-progenitor cell hematopoietic compartment can hyperproliferate to compensate
for profound deficiencies in marrow stem or progenitor
cells (Kaushansky et al. 2002). As such, we evaluated total
BM counts before and after 5 Gy irradiation to further
understand the factors involved in the increased radiosensitivity of p537KR mice. The total BM counts in WT
and p537KR mice were not significantly different prior to
irradiation (Fig. 2D). Consistent with previous studies
(Wang et al. 2006), the total BM cells from WT mice
dropped significantly by 4 d after irradiation, and then
started to recover by 2 wk post-irradiation. Four weeks
after irradiation, total BM cells increased to ;85% of
baseline levels. Importantly, total BM cells in p537KR mice
decreased to similar levels as WT at 4 d but remained
significantly lower at 2 and 4 wk post-irradiation (Fig. 2D).
We further quantified hematopoietic progenitor cells by
culturing marrow cells from WT and p537KR mice in
semisolid medium containing various growth factor combinations. Figure 2E shows that, compared with WT
animals, p537KR mouse marrow may contain slightly
fewer granulocytic/macrophage (CFU-GM), erythroid
(BFU-E), and megakaryocytic (CFU-MK) progenitor cells
prior to irradiation (differences are not statistically significant). Immediately following irradiation and isolation of
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Figure 2. Irradiation causes long-term defects
in p537KR hematopoietic progenitor cells. (A)
White blood cells (WBC) red blood cells (RBC),
and and platelets (PLT) in WT, p537KR, and p53null mice prior to irradiation. WT and 7KR: n =
13; null: n = 6. (B) Blood cell counts at 2 wk after
5 Gy of whole-body irradiation. (C) The fold
changes of blood cell counts in p537KR mice
related to WT mice 2 wk post-irradiation. (D)
Mononucleated cell (MNCs) count in BM at
baseline and 4, 14, and 28 d post-irradiation
revealed insufficient recovery of BM cells in
irradiated p537KR mice. (E) BM cells were isolated
from nonirradiated mice and seeded for granulocytic/macrophage (CFU-GM), erythroid (BFU-E),
and megakaryocytic (CFU-MK) progenitor cell
colony-forming assay. (F) BM cells were immediately isolated from animals that were exposed to
irradiation for progenitor colony-forming assay.
Note: No colonies were found when 5 3 106
p537KR BM cells were seeded for BFU-E assay.
The error bars in D, E, and F represent SEM from
three independent experiments.

marrow cells, we observed a 10- to 20-fold reduction of
colony-forming cells of all cell types in both WT and
p537KR mice, again with slightly fewer colony-forming
cells in p537KR mice (Fig. 2F). In contrast, and consistent
with lower total BM cell counts at 2 and 4 wk postirradiation (Fig. 2D), the mutant mice exhibited more
severe reductions in hematopoietic colony-forming progenitor cells when marrows were isolated 2 and 4 wk postirradiation (Supplemental Fig. S3).
p537KR BM cells compete poorly with WT cells
in transplantation and are more radiosensitive
The radiosensitivity observed in the colony formation
assays implies a defect in the progenitor and/or stem cell
compartments. We therefore used competitive BM transplantation to address whether the long-term stem cell
repopulating abilities of the WT and mutant differ. BM
cells from donor mice (WT or p537KR) expressing the
CD45.2 leukocyte cell surface marker were transplanted
into lethally irradiated recipient mice in fixed ratios with
WT competitor BM cells expressing the CD45.1 leukocyte
cell surface marker (Fig. 3A). Twelve weeks after transplantation, at which time only long-term HSCs (LT-HSCs)
contribute to hematopoiesis, mice were sacrificed and
leukocytes from peripheral blood and BM were analyzed

for expression of CD45.1 and CD45.2 using flow cytometry. As expected, WT donor cells (CD45.2) and competitor
cells (CD45.1) transplanted in equal amounts (2 3 105) into
lethally irradiated recipients competed almost equally to
repopulate the peripheral blood compartment (Fig. 3C). In
contrast, under the same experimental conditions, p537KR
CD45.2 donor cells only contributed to 1.2% of the
reconstituted peripheral blood cell populations at 12 wk
post-transplantation.
We further characterized the radiation-induced defect in
p537KR HSCs by performing the same competitive repopulation assays with irradiated WT and p537KR cells. BM cells
were isolated 4 d post-irradiation, as this corresponds to the
time of maximal radiation-induced BM cell lethality (Wang
et al. 2006). Since irradiation significantly affects multiple
hematopoietic cell types and can induce HSC senescence
(Meng et al. 2003), we used three or 10 times more
irradiated WT or p537KR cells than nonirradiated competitor cells to ensure the presence of some viable HSCs from
irradiated donors for engraftment. Under these experimental conditions, irradiation of WT donor cells produced a 10to 15-fold reduction in transplantation efficiency as compared with nonirradiated WT donor cells (Fig. 3C).
Identical analysis using p537KR donor cells revealed
such a profound defect in p537KR HSCs that none of
the reconstituting cells were derived from the mutant
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Figure 3. p537KR HSCs exhibit sensitivity to
transplantation and to irradiation. BM from
nonirradiated (A) and 4-d post-irradiated (B)
WT or p537KR donor mice expressing the
CD45.2 leukocyte cell surface marker were
transplanted into lethally irradiated recipient
mice in fixed ratios with WT competitor
marrow cells expressing CD45.1. (C) p537KR
HSCs did not compete as well as WT for longterm repopulation under both nonirradiated
and irradiated conditions. At 6 wk and 12 wk
post-transplantation, peripheral blood was
withdrawn from the recipients and analyzed
for the percentage of CD45.2 cells in total
leukocytes. Results show mean 6 SD from at
least five animals. a, b: P < 0.05. c, d: P <
0.001.

animals when threefold more irradiated p537KR cells were
cotransplanted with competitor WT cells. Even with 10fold more irradiated p537KR donor cells, mutant HSCs
were not capable of competing in the reconstitution of
the hematopoietic compartment (Fig. 3C). These data
reveal a profound defect in the ability of p537KR HSCs to
compete with WT HSCs for repopulation, and that this
phenotype is magnified by irradiation.
Unchallenged p537KR BM contains fewer HSCs
In addition to a reduced competitive fitness of the mutant
HSCs, we also explored the possibility that nonirradiated
p537KR BM contains fewer HSCs. We estimated HSC
numbers by enumerating Lin Scal1+cKit+ (LSK) cells,
a population of cells previously shown to be highly
enriched for HSCs (Wognum et al. 2003). We observed
that p537KR BM contains approximately two-thirds the
number of LSK cells as compared with WT BM (Fig. 4A;
Supplemental Fig. S4). We confirmed this result by sorting
for an independent set of HSC cell surface markers,
referred to as SLAM markers (Lin CD41 CD48 CD150+),
as this yields a population that contains 40%–50% HSCs
as determined by limiting dilution long-term repopulation
analysis (Kiel et al. 2005). As observed for LSK cells, SLAM
cells from p537KR marrows were ;40% the abundance of
similarly isolated cells from WT BM (Fig. 4B; Supplemental Fig. S4).
The radiosensitivity of p537KR animals resides
in the HSC and not in the stem cell niche
We next determined whether irradiation induces changes
in the HSC niche(s) in p537KR animals, as this could also
contribute to their reduced abundance and to their radio-
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sensitivity. We investigated this possibility by transplanting 1 3 106 WT (CD45.1) BM cells into either WT or p537KR
mice exposed to the lethal dose of 10 Gy whole-body
radiation (Fig. 4B). We observed that 100% of these lethally
irradiated p537KR mice survived after transplantation of
WT BM. FACS analyses showed that donor cells (CD45.1)
reconstituted the entire hematopoietic system by 6 wk
post-transplantation (Supplemental Fig. S5). The rescued
mice are thus chimeric in that their hematopoietic compartment is fully reconstituted by WT HSCs, while the
marrow niche and all other cells in these animals are
p537KR. CBC analysis showed that these WT:p537KR chimeras resisted 5 Gy of whole-body irradiation like WT:WT
chimaeras (Fig. 4C). This restoration of radioresistance
was not due to an effect of the age of the animals at the
time of analysis, as 23-wk-old p537KR mice (slightly older
than the irradiated chimeras) were still sensitive to the
same dose of irradiation (Supplemental Fig. S6). This result demonstrates that introducing WT HSCs by BM transplantation is sufficient to rescue the radiosensitivity of
p537KR animals.
p537KR function and radiosensitivity are affected
by Mdm2
Previous studies of the impact of Mdm2 and Mdmx
expression on p53 activity revealed that the p53 pathway
is exquisitely sensitive to p53 protein levels and basal
activity, which can be modulated by p53-negative regulators (Mendrysa et al. 2003; Terzian et al. 2007; Wang et al.
2009). Since Mdm2 heterozygous mice are known to have
elevated p53 activity (Terzian et al. 2007), we compared
their radiosensitivity with p537KR mice. Interestingly,
while half of p537KR mice died from 5 Gy ionizing
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Figure 4. The hematopoietic defects in p537KR mice
reside in HSCs/progenitor cells and not in the stem cell
niche. (A) BM cells were isolated from nonirradiated
mice and stained with antibodies against hematopoietic
lineage (Lin) markers and cell surface marks Sca1 and
c-Kit and analyzed by flow cytometry. Lin Sca1+c-Kit+
subpopulation were gated as HSC-enriched LSK cells.
Cell plots are shown in Supplemental Figure S4.
(B) Antibody cocktail lineage markers CD41, CD48,
and CD150 were used for the analysis. The
Lin CD41 CD48 CD150+ subpopulation was gated as
HSC-enriched SLAM cells. Cell plots are shown in
Supplemental Figure S4. (C) Introducing WT HSCs into
p53 7KR mice by BM transplantation overcame the
radiosensitivity of the animals. BM cells expressing
CD45.1 were transplanted into lethally irradiated WT
or p537KR mice. Twelve weeks later, the chimeric mice
were exposed to 5 Gy of irradiation followed by CBC
analysis. (A–C) Error bars represent the SEM from three
animals.

radiation (IR), all Mdm2+/ mice survived. Moreover, loss
of one Mdm2 allele in a p537KR background significantly
increased p537KR radiosensitivity (Fig. 5A). CBC and histopathological evaluation revealed that p537KR;Mdm2+/
mice exhibited a more severe radiation-induced pancytopenia concomitant with severe atrophy in the spleen and
BM (Fig. 5B,C). p537KR;Mdm2+/ BM also had slightly
fewer HSC-enriched SLAM cells at baseline when compared with p537KR;Mdm2+/+ littermates (Fig. 5E). It is
unlikely that genetic background differences underlie any
of these effects, as CBC analyses showed similar responses in the backcrossed p537KR and p537KR;Mdm2+/+
genotypes (Supplemental Fig. S7).
We next asked whether the relative radiosensitivity of
the various genotypes analyzed above correlated with
basal p53 protein levels. Surprisingly, the basal levels
of p53 in splenocytes from the different genotypes (Fig.
5D) showed no direct correlation with the severity of the
radiation response. At baseline, p53 level was slightly
higher in p537KR mice than in WT or Mdm2+/ animals,
while it was, if anything, slightly lower in the more radiosensitive p537KR;Mdm2+/ mice (Fig. 5D; Supplemental Fig. S8). In contrast, we observed a significant increase
in basal p21 protein levels in p537KR mice, and this was
substantially stronger in p537KR;Mdm2+/ mice. Furthermore, the p21 level in the p537KR;Mdm2+/ mice was the
highest of any genotype after irradiation, and this correlates with their exquisite radiosensitivity. Thus, the p21
levels parallel the relative radiosensitivity of each genotype analyzed. This raises the possibility that the p537KR
mutant activates a different transcriptional program than
p53WT, and that this program may be further modulated
by changes in Mdm2 levels.
p537KR exhibits differential transcriptional activity
Recent studies show that post-translational modifications
of different lysine residues in p53 can elicit differential

effects on gene regulation that have significant biological
consequences (Tang et al. 2008; W Gu, pers. comm.).
Therefore, we investigated whether the K-to-R mutations
we introduced into p53 C-terminal lysines also elicited
differential effects on target gene transcription that contribute to the radiosensitivity of the mutant animals. As
a first analysis, quantitative PCR (qPCR) measurements
revealed that the induced levels of proapoptotic puma and
noxa in the thymus and BM were very similar in WT
and p537KR after 5 Gy of whole-body irradiation, (Fig. 6A;
data not shown). Consistent with our previous studies
(Krummel et al. 2005), we found that p21 expression was
slightly higher in irradiated p537KR thymus compared with
WT thymus (Fig. 6B; Supplemental Fig. S9). Furthermore,
p21 was expressed at even higher levels in BM than in
thymus, and is reproducibly expressed at twofold higher
levels in the p537KR BM than in WT BM at baseline and
after irradiation (Fig. 6B; Supplemental Fig. S9).
We further studied the transcriptional response elicited
by p53 in BM and thymus in the different genotypes using
a microfluidic chip that enables qPCR analysis of 43 p53
target genes. This provided a greater sampling of genes to
explore and quantify genotype- and tissue-related differences in transcriptional activity. Cluster analysis allowed
us to identify gene clusters that were expressed differentially in tissues and/or in response to irradiation (Fig. 6C).
For example, cluster IV contains a subset of genes that
were highly induced by irradiation in the BM, while cluster
II contains genes that were highly induced in the thymus.
We noted that several proapoptotic genes (apaf1, bax,
puma, and noxa) are present in cluster II. Importantly,
these genes were induced to similar levels in WT and
p537KR animals. This result suggested that apoptosis might
be induced to similar high levels in the WT and mutant
animals in the thymus, and to similar but lower levels in
the BM. We investigated this directly by terminal deoxynucleotidyl transferase (TdT)-mediated dUTP nick endlabeling (TUNEL) assay. Figure 6D shows that cells in the
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Figure 5. Mdm2 dependence of radiosensitivity in p537KR mice. (A) Kaplan-Meier radiation survival curves. WT;Mdm2+/ (n = 9) and
p537KR;Mdm2+/ (n = 6) mice under the same genetic background were exposed to 5 Gy whole-body irradiation. Losing one allele of Mdm2
enhanced the radiosensitivity of p537KR mice. P < 0.001. (B) CBC analysis of p537KR;Mdm2+/+ and p537KR;Mdm2+/ mice before irradiation
(n = 9) and 2 wk after 5 Gy whole-body irradiation (n = 5) showed severe pancytopenia in p537KR;Mdm2+/ mice. (C) Histopathological
evaluation revealed that p537KR;Mdm2+/ mice that died from irradiation exhibited severe atrophy in the spleen and BM. (D) Western
analysis of p53 and p21 abundance in spleens isolated from WT, Mdm2+/ (M2+/ ), p537KR (7KR), and p537KR;Mdm2+/ (7KR;M2+/ )
mice prior to or 3 h after 5 Gy of whole-body irradiation. Actin blot provides a loading control. Intensities of p53 and p21 signals were
normalized to Actin signals and are presented as relative fold differences. (E) p537KR;Mdm2+/ mice exhibited a slightly lower frequency of
HSC-enriched SLAM cells when compared with p537KR;Mdm2+/+ mice. Error bars represent the SEM from three animals.

thymus and spleen start to undergo apoptosis at 3 h postirradiation and that the number of apoptotic cells increases
by 6 h. In contrast, few BM cells were apoptotic at this
time point. More importantly, there was no measurable
difference in apoptotic frequency of cells in WT and p537KR
mice (Supplemental Fig. S10).
In addition to the cluster analysis, we identified several
genes (Fig. 6C, highlighted in pink) whose expression was
strongly and differentially affected by the 7KR mutations.
Consistent with the above analyses, we observed higher
p21 expression in irradiated p537KR thymus than in
irradiated WT thymus (Fig. 6C; Supplemental Fig. S11)
and even higher p21 levels in irradiated p537KR BM (Fig.
6C; Supplemental Fig. S11). Indeed, these analyses
revealed p21 to be one of the most significantly upregulated p53-inducible genes we analyzed in irradiated
p537KR BM.
We next determined whether the significant differences in p21 expression correlated with IR-induced proliferation differences between WT and p537KR BM cells.
BrdU was administered to mice for 2 d, marrow was
isolated, and cells of different hematopoietic lineages
were analyzed for BrdU incorporation by flow cytometry.
Interestingly, we observed a slightly higher number of
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BrdU-positive (BrdU+) total BM-MNCs (BM mononucleated cells) in p537KR mice relative to WT mice at baseline
(Fig. 6E). However, the number of BrdU+ LSK cells, and
the more quiescent HSC-enriched LSKCD34 subpopulation, was lower in p537KR than in WT mice. Upon
irradiation, the number of BrdU+Lin cells, BrdU+LSK
cells, and BrdU+LSKCD34 cells were significantly lower
in p537KR mice than in WT mice (Fig. 6E). Taken together,
the data reveal differences in the hematopoietic cell cycle
kinetics in unirradiated p537KR and WT animals, with the
mutant manifesting greater sensitivity to radiation-induced withdrawal from the cell cycle.
p21 gene dosage affects radiosensitivity of p537KR mice
Several lines of evidence indicate that puma-mediated
apoptosis and p21-mediated cell cycle arrest contribute to
HSC abundance and functionality after irradiation (Cheng
et al. 2000; Meng et al. 2003; Shao et al. 2010; Yu et al.
2010). While WT and p537KR mice exhibited similar levels
of puma induction (Fig. 6B,C) and apoptosis at early times
after irradiation (Figs. 2D, 6D; Supplemental Fig. S10), p21
was significantly and differentially expressed in p537KR BM
cells. We determined whether the increased p21 induction
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Figure 6. Differential gene expression and cell cycle kinetics in p537KR mice. (A) The p53-inducible proapoptotic gene puma was
expressed at higher levels in thymus than in BM after irradiation. The level of puma expression was similar between WT and p537KR mice.
(B) The p53-inducible cell cycle arrest gene p21 was highly expressed in BM after irradiation, and showed even greater expression in
p537KR animals. (A,B) Error bars represent the SEM from three animals. (C) Expression of 43 p53 target genes from thymus (T) and BM (B)
prior to irradiation or 3 h post-irradiation (IR) was detected using microfluidic qPCR analysis. Relative expressions of each gene from all
samples were scaled from 0 to 1, followed by hierarchical clustering analysis. (Cluster I) Repressive or less responsive genes. (Cluster II)
Highly IR-induced genes in thymus. (Cluster III) Genes highly affected by 7KR mutations in BM. (Cluster IV) Highly IR-induced genes in
BM. (Cluster V) Highly expressed genes in BM. The analysis suggests that several genes (highlighted in pink) are differentially affected by
the 7KR mutations. (D) Thymi, spleens, and BM were isolated from mice at 0, 3, and 6 h after 5 Gy of whole-body irradiation. Apoptosis
was detected by TUNEL staining (green). (E) Nonirradiated mice or mice exposed to 5 Gy of irradiation were injected with 2 mg of BrdU
followed by 2-d administration of BrdU water (1 mg/mL). BMs were then isolated and stained with antibodies against lineage (Lin)
markers; cell surface markers Sca1, c-kit, and CD34; and BrdU, followed by flow analysis. BrdU incorporated cell in Lin , LSK
(Lin Sca1+c-kit+) and LSKCD34 subcell populations were analyzed. Error bars represent the SD from three animals.
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was functionally relevant to the radiosensitivity of p537KR
mice by determining whether reducing p21 gene dosage
would reduce the p537KR radiosensitivity. We crossed
p537KR mice with p21+/ mice to obtain p537KR;p21+/
mice, and found a significant increase in radioresistance in
these mice. For example, we observed no mortality in
p537KR;p21+/ mice at least 6 wk after exposure to 5 Gy
radiation (Supplemental Fig. S12). When mice were exposed to 6 Gy radiation, almost 100% of p537KR;p21+/+
mice died within 4 wk of irradiation, while 50% of
p537KR;p21+/ littermates survived during the same time
period. By 8 wk after irradiation, 30% of p537KR;p21+/
mice were still alive (Fig. 7A). Western blot analysis and
gene expression confirmed that p21 levels were lower in
irradiated p537KR;p21+/ mice relative to irradiated
p537KR;p21+/+ mice (Fig. 7B,C). When HSC-enriched SLAM

Figure 7. p21 gene dosage affects radiosensitivity of p537KR
mice. (A) Kaplan-Meier radiation survival curves. Littermate
p537KR;p21+/+ (n = 7) and p537KR;p21+/ (n = 10) mice were
exposed to 6 Gy of whole-body irradiation. Losing one allele of
p21 partially rescued the sensitivity of p537KR mice to 6 Gy
irradiation. P = 0.06. (B) Analysis of gene expression in thymus
and BM showed that p21 expression was reduced by half in
p537KR;p21+/ mice (p21+/ ), while puma expression was not
affected. Error bars represent the SEM from three animals. (C)
Western analysis showed reduced p21 levels in irradiated
p537KR;p21+/ mice, while p53 levels were unchanged. (D)
p537KR;p21+/ mice exhibited slight lower frequency of HSCenriched SLAM cells when compared with p537KR;p21+/+ mice.
Error bars represent the SEM from three animals.
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cells were analyzed, we observed slightly more SLAM cells
in p537KR;p21+/ BM (Fig. 7D), although the increase did
not achieve statistical significance. Together, our data
demonstrate the importance of proper C-terminal p53
modification to ensure that the p53-dependent cell cycle
arrest function is appropriately regulated. Furthermore,
they reveal the importance of properly regulated p53induced cell cycle arrest for hematopoietic system recovery after genotoxic stress. They also indicate that p21
contributes to, but is likely not the only factor responsible
for, the increased radiosensitivity of p537KR mice.
Discussion
Our data provide the first evidence that post-translational
modifications at highly conserved lysines in the p53
C-terminal regulatory domain are critically important
for fine-tuning p53 activity to properly maintain hematopoietic system homeostasis and enable appropriate
responses to DNA damage. The inability to post-translationally modify these sites leads to altered expression of
a subset of genes that prevents the timely re-entry of
HSCs and progenitors into the cell cycle to enable recovery from radiation-induced myelosuppression. A combination of gene expression and genetic strategies reveal
that this aberrant response is due in part to elevated
expression of the cyclin-dependent kinase inhibitor p21,
although other factors are also likely involved.
Our studies reveal a differential capacity for p537KR to
regulate a subset of target genes in subtypes of cells in the
hematopoietic system following genotoxic stress. Our data
show that p53-induced proapoptotic genes, including
puma, bax, noxa, and apf1, are expressed at relatively high
levels in fully differentiated cells (thymocytes and splenocytes) after irradiation. In contrast, genes that are involved
in the cell cycle, such as p21, pten, and fbxw7, are highly
expressed in hematopoietic stem or progenitor cells (BM
and Lin cells) after irradiation (Fig. 5). The ability of p53 to
differentially regulate genes is likely to be dependent on
additional factors such as its binding affinity to the distinct
p53 response elements in each promoter as well as promoter chromatin structure, binding of other regulatory
proteins, availability of cofactors, etc. (for review, see
Espinosa 2008). Here, we provide the first in vivo evidence
that modifications in the highly conserved C-terminal
regulatory domain contribute to differential, tissue-specific gene regulation. The subset of genes that were altered
by the 7KR mutations was distinct from that identified in
Mdm2+/ cells (Fig. 6C; Supplemental Fig. S13), suggesting
that induction of different p53 response programs can be
regulated by C-terminal modifications. The importance of
this region in p53 transcriptional control is consistent with
structural studies indicating that the loose, positively
charged residues within this highly conserved regulatory
domain facilitate target gene identification by enabling
p53 to encircle and slide along DNA (Jayaraman and Prives
1995; Weinberg et al. 2004; Tidow et al. 2007). Our data
demonstrate that p21 is one of the most exquisitely
sensitive p53 response genes affected by p53 C-terminal
modification in hematopoietic cells. Interestingly, DNA
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sequence and biochemical analyses indicate that the p21
gene contains one of the strongest p53-binding sites (Inga
et al. 2002), and the gene may be poised to express rapidly
due to both a special configuration of the transcriptional
apparatus and the presence of preloaded polymerase II
(Espinosa et al. 2003). Together, such factors likely enable
p21 to manifest significant changes in the face of subtle
alterations in p53 abundance or binding. It is possible that
other genes that are hyperresponsive to p537KR exhibit
similar properties.
Control of p53 abundance and activity are clearly
critical for survival and response to oncogenic and genotoxic stresses (Wade et al. 2010). Mdm2 plays key roles in
both levels of control by virtue of its ubiquitin ligase
activity and its ability to bind to the N-terminal TAD and
inhibit p53-dependent effects on transcription. Our data
clearly show that preventing C-terminal lysine modifications targeted by Mdm2 for ubiquitylation is apparently
not sufficient to completely stabilize p53, as p537KR levels
still increase after irradiation (Fig. 5D). This may be due to
the use of alternative ubiquitylation sites, as indicated by
our previous study showing that p537KR is aberrantly
ubiquitylated (Krummel et al. 2005). However, the activity
of the p537KR mutant is still exquisitely sensitive to
Mdm2, as removing only one Mdm2 allele significantly
increased radiosensitivity of p537KR mice but not p53WT
mice in response to 5 Gy irradiation (Fig. 5A). Given this
result, we were surprised to find that p53 levels do not
strictly correlate with Mdm2 in the case of p537KR
animals. Thus, while p53WT increased about twofold, at
baseline, in Mdm2+/ animals, p537KR levels were, if
anything, slightly less abundant in p537KR;Mdm2+/ than
p537KR;Mdm2+/+ animals at baseline and after irradiation
(Fig. 5D, lanes 5–8). Interestingly, Mendrysa et al. 2003,
2006) have made similar observations using mice that
express ;30% of the WT level of Mdm2. In their analyses,
the thymus in Mdm2puro/D7–12 mice was smaller, and they
observed increased p53 activity with similar to lower p53
levels. They also reported that the mutant thymus and
spleen contained reduced numbers of leukocytes, indicating how p53 activity can affect cellular composition in
these organs. Furthermore, their analyses showed significant decreases of WBCs in Mdm2puro/D7–12 mice than
Mdm2puro/+ and Mdm2+/ mice. These results are similar
to what we observed in p537KR;Mdm2+/ , p537KR, and
Mdm2+/ mice (Fig. 5B; Supplemental Fig. S7). Thus, the
altered cellular composition in the p537KR;Mdm2+/
spleens might contribute to p53 levels that are significantly different from WT, especially when employing
methods such as Western blotting that detect protein
levels in mixed cell populations. It is also possible that
p537KR;Mdm2+/ cells with low p53 levels were positively
selected through development. While the exact mechanism underlying the observed difference requires further
investigation, it seems even at WT levels of expression, the
C terminally altered p537KR protein is more efficient than
p53WT at regulating a subset of genes in BM, such as p21.
Radiosensitivity in the hematopoietic system is determined by the severity of irradiation-induced apoptosis in
mature blood cells during the acute phase, and by the

ability of HSCs and progenitors to repopulate and replace
the damaged cells during the recovery phase. The proapoptotic gene puma and cell cycle arrest gene p21 are two
well-studied p53-inducible genes reported previously to
contribute to radiosensitivity and HSC regulation. While
puma deficiency protects HSCs from high-dose radiationinduced damage (Shao et al. 2010; Yu et al. 2010), the role
of p21 in HSC regulation remains controversial owing to
conflicting reports that the expanded HSC pool in p21deficient mice is exhausted over time due to inappropriate
cell cycle entry (Cheng et al. 2000; van Os et al. 2007).
Other studies reporting increased radiosensitivity in Atmand p21-deficient mice (Wang et al. 1997; Ito et al. 2007)
suggest that the loss of cell cycle control in such animals
generates defects in G1/S boundary control that could
result in unscheduled S-phase entry and p53-dependent
and -independent death processes. On the other hand,
overexpressing p21, which was observed in irradiated
p537KR BM, could result in a significant number of HSCs
or progenitor cells undergoing cell cycle arrest. This could,
in turn, cause a delay or insufficient repopulation of
hematopoietic cells during the recovery phase after irradiation or other forms of genotoxic myelosuppression.
Consistent with this, we found significantly less BrdU
incorporation in irradiated p537KR HSC and progenitor
compartments (Fig. 6E) and low BM cellularity 2 and 4 wk
after irradiation (Figs. 2D; Supplemental Fig. S2). Intriguingly, we also observed greater BrdU incorporation in
p537KR total BM-MNCs relative to WT during homeostasis (Fig. 6E). Since p537KR mice contain similar numbers of
total BM cells at baseline (Fig. 2D), it is conceivable that
the reduced HSC frequency in p537KR mice (Fig. 4A,B)
might trigger a positive compensating stimulus that results in more progenitor or terminally differentiated cells
entering cell cycle to generate sufficient mature cells to
sustain hematopoiesis (Jankovic et al. 2007; Madan et al.
2009). In our study, reducing p21 levels by losing one allele
of p21 completely rescued radiosensitivity of p537KR mice
at 5 Gy, and partially rescued at 6 Gy of g-irradiation,
suggesting that complete restoration of HSC function in
p537KR mice after irradiation likely requires additional
factors. While puma and other proapoptotic genes clearly
contribute to p53-dependent radiosensitivity, such genes
were not differentially up-regulated in the p537KR mutant
(Fig. 6C), raising the possibility that other genes that are
expressed at greater levels in the mutant may contribute to
its radiosensitive phenotype. Candidates for genes include
those in Figure 6C that are highly up-regulated in the
p537KR mutant (highlighted in pink).
We also observed that p537KR BM exhibited extremely
low repopulating efficiency in the competitive BM transplant assay even in the absence of irradiation. It is possible
that transplant-associated stress (Lahav et al. 2005) cooperates with the elevated basal p53 activation of p537KR
HSCs and progenitors to produce the observed low repopulating efficiency of nonirradiated p537KR BM (Fig. 3). A
homing defect preventing p537KR HSCs from accessing the
hematopoietic niche could also contribute to their low
repopulating efficiency. We have no direct evidence for
such a deficiency, and note that p537KR cells were present
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in both circulating peripheral blood and BM 6 and 12 wk
after transplant. However, we cannot rule out the possibility that p537KR cells might exhibit different homing
kinetics, which causes a delay in HSC niche engraftment.
Recently, p53 activity level has been demonstrated to be
a critical determinant of the ability of stem cells to
compete in the setting of BM transplantation (Bondar
and Medzhitov 2010; Marusyk et al. 2010). Similar to
our observations, Bondar and Medzhitov (2010) found that
cell cycle regulation plays an important role in p53dependent HSC competition. Our data add a mechanistic
function to explain roles for p53 in transplantation competitiveness by showing that p21 levels can profoundly
influence HSC/progenitor fitness, and that the p53 Cterminal regulatory domain appears to be one element at
which signals elicited during transplantation are processed.
This competition model implies that cells with compromised p53 function may gain selective advantages and
contribute to tumor development or evolution.
Together, our and other studies (Mendrysa et al. 2003;
Terzian et al. 2007; Wang et al. 2009) reveal the exquisite
sensitivity of the hematopoietic system to modest elevations or reductions in p53 activity. By extension, transient antagonism of p53 activity could be protective in
situations where environmental or chemotherapeutic
genotoxins would otherwise be cytotoxic in normal tissues and stem cells (Gudkov and Komarova 2007). Furthermore, we and others previously showed that suppressing p53 activity enhances reprogramming of differentiated
cells to pluripotent stem cells (Kawamura et al. 2009;
Krizhanovsky and Lowe 2009). An implication of the data
shown here is that transient p53 antagonism could also be
beneficial for in vitro stem cell culturing to prevent stressinduced stem cell senescence, as BM transplants often
require HSC enrichment or expansion ex vivo. In vivo,
inappropriate repression of p53 C-terminal acetylation in
PML-RAR oncoprotein-associated acute promyelocytic
leukemia (APL) (Insinga et al. 2004) may compromise
p53 activity sufficiently to enable rare leukemic stem cells
to self-renew, generate leukemic blasts, and fuel leukemia
progression. Interestingly, acute leukemias rarely contain
p53 mutations but do exhibit compromised p53 function
(Dino et al. 1994). The enhanced understanding of p53
regulation in HSC homeostasis and recovery from genotoxic injury afforded by these analyses suggest routes to
the development of therapeutic approaches to spare or
protect the hematopoietic system.

irradiation study, age- and gender-matched mice were exposed to
whole-body irradiation with a 60Co g-irradiator at an average rate
of 0.5 Gy/min. All mice used in the study were between 8 and 12
wk of age. All mouse maintenance and procedures were approved
by the Animal Care and Use Committee of the Salk Institute.
Histochemical analysis
Tissues were isolated from mice and fixed in 10% neutral
buffered formalin (Protocol) for 24 h. Bones were decalcified in
Cal-Ex solution (Thermo-Fisher). Fixed tissues were embedding
in paraffin. Paraffin sections were deparaffinized and heated in 10
mM citrate buffer (pH 6) in a microwave for antigen retrieval.
The sections were then stained with H&E for pathological
analysis. Apoptosis was determined by TUNEL assay using In
Situ Cell Death Detection kit, Fluorescein (Roche).
Colony-forming cell assay
BM cells were flushed from femurs and tibias using IMDM
medium (Gibco) containing 2%FBS. Cells were triturated and
filtered through a nylon screen to obtain a single-cell suspension.
An aliquot of cells were stained with Turk solution for MNC
counting. BM-MNCs (5 3 105;5 3 106) were plated for colonyforming cell assay using MethoCult and MegaCult-C (Stem Cell
Technologies) following the manufacturer’s instructions. Cells
were incubated at 37°C with 5% CO2 and >95% humidity.
Colonies of CFU-GM and BFU-E were scored on day 7 and
colonies of CFU-Mk were scored on day 12.
Competitive long-term reconstitution assay
Donor BM-MNCs were isolated from WT or p537KR mice (C57Bl/
6-Ly5.2) and mixed with 2 3 105 competitive BM-MNCS isolated
from congenic C57Bl/6-Ly5.1 mice. The mixture was retroorbitally injected into lethally irradiated recipients (C57Bl/6Ly5.1). Twelve weeks post-transplants, reconstitution of donor
leukocytes were analyzed by staining blood cells or BM with
antibodies against leukocyte cell surface markers CD45.1 and
CD45.2 (BD Pharmingen) using flow cytometry.
Western blot analysis
Cells or tissues were lysed in RIPA buffer (50 mM Tris-HCl at pH
7.4, 150 mM NaCl, 0.1% SDS, 0.5% sodium deoxycholate, 1%
NP40, 10 mM Na3VO4, 100 mM NaF, protease inhibitor cocktails [complete tablet, Roche]). Protein extracts were analyzed by
Western blotting using antibodies specific for p53 (1C12, Cell
Signaling), p21 (BD Pharmigen), and Actin (Sigma).
Real-time RT–PCR

Materials and methods

Total RNA from thymus or BM was isolated using RNeasy mini
kit (Qiagen) and subjected to real-time qPCR as described
previously (Krummel et al. 2005).

Mice and irradiation procedure

Microfluidic qPCR

C57Bl/6-Ly5.2 and C57Bl/6-Ly5.1 mice were purchased from
Taconic. p537KR mice were generated previously (Krummel et al.
2005) and backcrossed to C57Bl/6 background. p537KR mice that
were used in the study are in B6 or a mixed B6/129 background.
Mdm2+/ mice (kind gift of G. Lozano) are in a mixed B6/129
background. The p21+/ mice used here (K Tinkum, D PiwnicaWorms, and H Piwnica-Worms, in prep.) are in a mixed B6/129
background; Supplemental Figure S14 shows that this p21 knockout allele expresses no detectable p21 following irradiation. For the

Total RNA from thymus or BM was isolated using an RNeasy
mini kit (Qiagen). The first strand cDNA was synthesized using
SuperScript III kit (Invitrogen) followed by specific target amplification using primer pair sets specific for p53-induced genes and
hprt and gapdh as controls. Preamplified gene expression assays
were provided by Fluidigm Assay Design. Specific target amplification PCR products were loaded onto a 48.48 Dynamic Array
Integrated Fluidic Circuits (Fluidigm), and qPCR thermal cycling
was performed using a BioMark instrument (Fluidigm) following
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the manufacturer’s instructions. Data were analyzed using Fluidigm
Melting Curve Analysis software (Fluidigm). Expression of p53induced genes was normalized to the average signals of control
genes hprt and gapdh, and relative expression of each gene from
all the samples was scaled from 0 to 1. Hierarchical clustering was
performed using MeV 4.4 software (TM4 microarray software
suite).
Flow cytometry
Antibodies are purchased from BD Pharmingen or mentioned
elsewhere. BM cells were incubated with FITC or biotinconjugated antibodies against lineage markers including B220,
CD3, Gr1, Mac1, Ter119, biotin, or PerCP-Cy5.5-conjugated
anti-c-Kit; PE- or APC-conjugated anti-Sca1 (Biolegend); APCCy7-conjugated stretavidin; FITC-conjugated anti-CD41 and
anti-CD48; PE-conjugated anti-CD150 (Biolegend), and FITCconjugated anti-CD34 (eBioscience). Cells were analyzed using
FACScan, LSRI, or LSRII (Becton-Dickinson), and data were
analyzed using CellQuest Pro and FlowJo software.
BrdU incorporation
Mice were intraperitoneally injected with 2 mg of BrdU (Sigma)
followed by the administration of BrdU (1 mg/mL) in the
drinking water for 2 d. Mice were sacrificed and BM cells were
isolated for the analysis of BrdU incorporation using APC BrdU
flow kit (BD Biosciences).
Statistical analysis
We used the two-way t-test for analyzing differences between
two groups. Data are represented as mean 6 SEM unless otherwise noted, with values of P < 0.05 considered significant.
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